Acute Myeloid Leukemia

Overview of attention for article published in Hematology, January 2004

Altmetric Badge

Mentioned by

policy: 1 policy source
patent: 4 patents

guideline: 1 clinical guideline source

Readers on

mendeley: 179 Mendeley
citeulike: 1 CiteULike

So far, Altmetric has seen 1 policy document that references this research output.

Gemtuzumab ozogamicin for untreated acute myeloid leukaemia : Appraisal consultation committee papers

Cited by National Institute for Health and Care Excellence (NICE) on 18 May 2018

The National Institute for Health and Care Excellence (NICE) in the UK provides national guidance and advice to improve health and social care.

This page shows the most recent policy documents that mention this research output. Click here to find out how to access more activity.